AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Safer Estrogen Targets Painful Intercourse In Older Women.(new estrogen treatment for vaginal atrophy)
2001 JUN 7 - (NewsRx Network) -- Researchers at Yale University's School of Medicine have designed a new form of estrogen that could improve the treatment of vaginal atrophy, commonly referred to as vaginal dryness.
Experienced by many postmenopausal and other women with lost or diminished ovarian function, the condition can result in pain during sexual intercourse. The study will appear in the June 7, 2001, issue of the Journal of Medicinal Chemistry.
"We have synthesized the first locally active estrogen with no systemic effect [in animal studies]," said Richard Hochberg, PhD, the lead investigator in the study and a professor in Yale's Department of Obstetrics and Gynecology in New Haven, Connecticut.
Although vaginal atrophy can be effectively treated with estrogen replacement therapy, this has been associated with certain health risks, including breast cancer, endometrial cancer, and stroke, leading many women to avoid this therapy altogether. Unlike the normal estrogen molecule, the new compound acts only on the tissue to which it is applied, reducing risks and providing a potentially safer alternative, the researchers say.
They suggest that the modified estrogen could be particularly helpful in treating vaginal atrophy in women for whom estrogen replacement is not advised, including those with breast or endometrial cancer.
The drug has not yet been tested in humans. If the new estrogen ultimately proves to restore some of the physical comfort of sexual intercourse in postmenopausal women while reducing health risks, it could provide an important new tool in the treatment of female sexual dysfunction in much the same way that [Viagra.sup.r] has helped relieve impotence in some men, predicts Hochberg.
Vaginal dyspareunia, the medical term for vaginal atrophy, most often occurs in women after menopause. Studies have shown that more than 40% of postmenopausal women experience the condition, which causes thinning of the vaginal wall, dryness, and itching, and leads to painful intercourse and ...
- QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal...
- Press release article from: PR Newswire March 31, 2009 700+ words
...under the published FDA guidance for vaginal atrophy. "We are pleased to have achieved...what we believe to be the largest vaginal atrophy study ever conducted," said Robert...for the treatment of postmenopausal vaginal atrophy." The randomized, double-blind...
- New Position Statement from The North American Menopause Society Addresses Use...
- Press release article from: Business Wire May 10, 2007 700+ words
...estrogen therapy for the treatment of vaginal atrophy, a frequent complaint of postmenopausal...vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position...resolve spontaneously. Left untreated, vaginal atrophy can result in years of discomfort...
- The agony of vaginal atrophy. (The Doctor's Casebook)(includes related...
- Newspaper article from: Nutrition Health Review Flatto, Edwin March 22, 1990 700+ words
The Agony of Vaginal Atrophy Q: I'm over sixty and remarrying. My problem is vaginal atrophy. Can you suggest a "drugless" preparation...many postmenopausal women experience vaginal atrophy as a result of insufficient estrogen...
- Drug Developed at the University of California, Davis May Prevent Breast...
- News wire article from: Europe Intelligence Wire November 1, 2005 700+ words
...clinical testing as a treatment for vaginal atrophy, may also help to prevent breast...early next year for the treatment of vaginal atrophy, a common condition among postmenopausal...fragile vaginal lining. Known as vaginal atrophy, the problem affects 10 to 40 percent...
- Drug Developed at the University of California, Davis May Prevent Breast...
- News wire article from: AScribe Health News Service November 1, 2005 700+ words
...clinical testing as a treatment for vaginal atrophy, may also help to prevent breast...early next year for the treatment of vaginal atrophy, a common condition among postmenopausal...fragile vaginal lining. Known as vaginal atrophy, the problem affects 10 to 40 percent...
- Bionovo's Drug Candidate Shows In Vivo Safety and Efficacy in the Treatment of...
- Press release article from: PR Newswire June 16, 2008 700+ words
...and effective for the treatment of vaginal atrophy or "vaginal dryness." "Vaginal...designed for the treatment of menopausal vaginal atrophy. VG101 is manufactured from substances...million women of menopausal age. Vaginal atrophy and dryness, is experienced by 55...
- Vaginal atrophy returns 4 weeks after stopping ERT. (Study of 20 Postmenopausal...
- Magazine article from: OB GYN News Bates, Betsy July 1, 2002 700+ words
...estrogen replacement therapy return to baseline levels of vaginal atrophy within 4 weeks, according to results of a study presented...the time it takes a woman to return to baseline levels of vaginal atrophy following discontinuation of estrogen. "We talked to many...
- Women return to pre-HRT vaginal atrophy in 4 weeks. (Results of Small...
- Magazine article from: Family Practice News Bates, Betsy October 1, 2002 700+ words
...estrogen replacement therapy return to baseline levels of vaginal atrophy within 4 weeks, according to findings presented at the...the time it takes a woman to return to baseline levels of vaginal atrophy following discontinuation of ERT. "We talked to many physicians...
- QuatRx completes enrolment of Ophena (ospemifene tablets) final pivotal Phase...
- News wire article from: Chemical Business Newsbase March 31, 2009 700+ words
...requirements for an NDA filing under the published FDA guidance for vaginal atrophy. The randomized, double-blind study has enrolled over...selective estrogen receptor modulator for the treatment of vaginal atrophy. QuatRx Pharmaceuticals is focused on the discovery, licensing...
- Draft guidance for industry on estrogen and estrogen/progestin drug products to...
- News wire article from: Asia Africa Intelligence Wire January 31, 2003 700+ words
...guidance for industry entitled "Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms--Recommendations for Clinical Evaluation." The agency is revising its guidance for industry entitled "Guidance...
Source: HighBeam Research, Safer Estrogen Targets Painful Intercourse In Older Women.(new...